Oops,
We can’t find the page you’re looking for. But hey, checkout these articles, perhaps they will take you somewhere new?
Pharmatimes Ad
Moderna has unveiled a new Omicron COVID-19 vaccine that it says is five times more effective at boosting antibodies compared to its previous jab. The vaccine, which would also protect against the initial Wuhan strain, may only need to be administered once a year.
A few weeks ago, the FDA warned of an amoxicillin shortage that may affect paediatric patients in the US; that shortage has now come to a head amid emergency room waiting times of up to 15 hours in some US hospitals. Many pharmacies across the country are also reportedly struggling to keep up with demand for the drug.
Pharmatimes.com/communications_awards
Www.pharmatimes.com/croy
The 2023 International Clinical Researcher of the Year - entry deadline is approaching